• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在犬类中,重组组织型纤溶酶原诱导溶栓后,前列环素类似物伊洛前列素未能维持冠状动脉血流。

Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs.

作者信息

Nichols W W, Nicolini F A, Khan S, Saldeen T G, Mehta J L

机构信息

Department of Medicine, University of Florida College of Medicine, Gainesville.

出版信息

Am Heart J. 1993 Aug;126(2):285-92. doi: 10.1016/0002-8703(93)91041-c.

DOI:10.1016/0002-8703(93)91041-c
PMID:7687816
Abstract

The coronary artery often reoccludes soon after the flow has been restored with recombinant tissue-type plasminogen activator (TPA) in dogs with electrically-induced thrombosis. The coronary artery reocclusion relates to intense in situ platelet activation and thrombin generation in the reperfused coronary artery. To determine the effect of a potent platelet inhibitor, the prostacyclin analog iloprost, in the prevention of coronary artery reocclusion, an occlusive thrombus was created in the left anterior descending coronary artery in 23 dogs. Coronary artery reflow occurred in 17 dogs after TPA (1 mg/kg over 20 minutes intravenously) administration. After the reflow was established, 10 dogs were given saline and 7 dogs were given iloprost (4 micrograms/kg over 40 minutes). In the saline-treated group, the coronary artery reoccluded in 8 of 10 dogs over 90 minutes (reocclusion rate 80%). In the iloprost-treated group, the coronary artery reoccluded in five of seven dogs (reocclusion rate 71%; p = NS vs TPA alone). The magnitude of peak coronary blood flow and duration of flow were similar in dogs given saline or iloprost after TPA-induced thrombolysis. Scanning electron microscopy showed residual thrombus and the appearance of coronary arterial narrowing distal to the thrombus in all dogs examined. Thus residual thrombus formation and coronary artery narrowing continue to occur after TPA-induced thrombolysis in dogs whether the animals are treated with saline or iloprost. Administration of iloprost after reflow does not modulate the frequency of coronary artery reocclusion.

摘要

在用电诱导血栓形成的犬中,使用重组组织型纤溶酶原激活剂(TPA)恢复血流后,冠状动脉常很快再次闭塞。冠状动脉再闭塞与再灌注冠状动脉中强烈的原位血小板活化和凝血酶生成有关。为了确定强效血小板抑制剂前列环素类似物伊洛前列素在预防冠状动脉再闭塞中的作用,在23只犬的左前降支冠状动脉中制造了闭塞性血栓。静脉注射TPA(1mg/kg,持续20分钟)后,17只犬出现冠状动脉再灌注。再灌注建立后,10只犬给予生理盐水,7只犬给予伊洛前列素(4μg/kg,持续40分钟)。在生理盐水治疗组中,10只犬中有8只在90分钟内冠状动脉再次闭塞(再闭塞率80%)。在伊洛前列素治疗组中,7只犬中有5只冠状动脉再次闭塞(再闭塞率71%;与单独使用TPA相比,p=无显著性差异)。TPA诱导溶栓后给予生理盐水或伊洛前列素的犬,冠状动脉血流峰值大小和血流持续时间相似。扫描电子显微镜显示,在所有检查的犬中均有残余血栓,且血栓远端冠状动脉出现狭窄。因此,无论动物接受生理盐水还是伊洛前列素治疗,TPA诱导溶栓后犬体内仍会继续形成残余血栓和冠状动脉狭窄。再灌注后给予伊洛前列素并不能调节冠状动脉再闭塞的频率。

相似文献

1
Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs.在犬类中,重组组织型纤溶酶原诱导溶栓后,前列环素类似物伊洛前列素未能维持冠状动脉血流。
Am Heart J. 1993 Aug;126(2):285-92. doi: 10.1016/0002-8703(93)91041-c.
2
Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis.前列环素类似物伊洛前列素降低犬冠状动脉血栓形成中组织型纤溶酶原激活剂的溶栓潜力。
Circulation. 1990 Mar;81(3):1115-22. doi: 10.1161/01.cir.81.3.1115.
3
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.硝酸甘油联合治疗未能提高组织型纤溶酶原激活剂对冠状动脉血栓形成疗效的病理基础。
Cardiovasc Res. 1991 Apr;25(4):283-9. doi: 10.1093/cvr/25.4.283.
4
Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.氧自由基清除剂在犬冠状动脉溶栓模型中作为组织型纤溶酶原激活剂辅助治疗的研究
Cardiovasc Res. 1993 Jun;27(6):925-34. doi: 10.1093/cvr/27.6.925.
5
Combined thrombolytic effects of tissue-plasminogen activator and a fibrinogen-degradation product peptide 6A or iloprost.组织型纤溶酶原激活剂与纤维蛋白原降解产物肽6A或伊洛前列素的联合溶栓作用。
J Cardiovasc Pharmacol. 1991 Aug;18(2):231-6. doi: 10.1097/00005344-199108000-00009.
6
Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis.低分子量肝素与重组组织型纤溶酶原激活剂联合治疗可使犬冠状动脉血栓形成持续再灌注。
Am Heart J. 1992 Aug;124(2):280-8. doi: 10.1016/0002-8703(92)90588-m.
7
Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.在冠状动脉溶栓过程中,阿司匹林不会增强次优剂量凝血酶抑制剂依诺加群的效果。
Cardiovasc Res. 1995 Dec;30(6):866-74.
8
Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis.在犬冠状动脉血栓形成模型中,含RGD肽echistatin对组织型纤溶酶原激活剂诱导的溶栓后再闭塞的预防作用。
Pharmacology. 1991;42(6):340-8. doi: 10.1159/000138817.
9
Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.超氧化物歧化酶可减少再灌注心律失常,并在使用组织纤溶酶原激活剂进行溶栓治疗期间维持心肌功能。
J Cardiovasc Pharmacol. 1990 Jul;16(1):112-20. doi: 10.1097/00005344-199007000-00016.
10
Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.低剂量血小板纤维蛋白原受体拮抗剂与直接凝血酶抑制剂联合使用可显著改善溶栓效果。
Circulation. 1994 Apr;89(4):1802-9. doi: 10.1161/01.cir.89.4.1802.

引用本文的文献

1
2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics.2022 年兽医重症监护领域抗栓和溶栓药物合理应用共识更新(CURATIVE)第六域:定义溶栓药物的合理应用。
J Vet Emerg Crit Care (San Antonio). 2022 Jul;32(4):446-470. doi: 10.1111/vec.13227.
2
Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.新型前列腺素I2类似物贝拉前列素钠对劳力型心绞痛患者止血、纤溶及心肌缺血参数的影响
Cardiovasc Drugs Ther. 1995 Aug;9(4):601-7. doi: 10.1007/BF00878093.
3
Antiplatelet drugs. A comparative review.
抗血小板药物。一项比较性综述。
Drugs. 1995 Jul;50(1):7-28. doi: 10.2165/00003495-199550010-00002.